e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Catia Cilloniz Campos (Barcelona, Spain), Catia Cilloniz, Richard Albert, Adamanthia Liapikou, Albert Gabarrus, Ernesto Rangel, Josep Mensa, Antoni Torres
Source:
International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Session:
Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Session type:
Poster Discussion
Number:
1843
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Catia Cilloniz Campos (Barcelona, Spain), Catia Cilloniz, Richard Albert, Adamanthia Liapikou, Albert Gabarrus, Ernesto Rangel, Josep Mensa, Antoni Torres. The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia. Eur Respir J 2015; 46: Suppl. 59, 1843
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Community-acquired pneumonia due to
streptococcus pneumoniae
in hospitalized patients – mortality predictors
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of
streptococcus pneumoniae
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Streptococcus pneumoniae infection is an independent cause of cardiac rhythm alteration in community-acquired pneumonia
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015
Are there differences in Pneumonia sp. pneumoniae in patients with community-acquired pneumonia patients and institutionalized?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Fast replicating strains of streptococcus pneumoniae are associated with severe community-acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Penicillin-resistant
streptococcus pneumoniae
is a rare etiology of community-acquired pneumonia requiring hospitalization: results from the CAPO international cohort study
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009
Early mortality in patients with community-acquired pneumonia: causes and risk factors
Source: Eur Respir J 2008; 32: 733-739
Year: 2008
Community-acquired pneumonia (CAP) caused by
mycoplasma pneumoniae
or
chlamydophila pneumoniae
in children: Are there reliable signs/symptoms for clinical diagnostics?
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013
Severe
Chlamydia pneumoniae
community-acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 545s
Year: 2003
Dynamic of resistance of streptococcus pneumoniae strains from patients with CAP in theritary tertyary hospital: 10 years prospective study
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Monitoring of
Mycoplasma pneumoniae
and
Chlamydia pneumoniae
in young patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2001; 18: Suppl. 33, 140s
Year: 2001
Influence of streptococcus pneumoniae serotypes in clinical outcomes of pneumonias
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
Klebsiella respiratory infection community acquired
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept